+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Live Biotherapeutic Products CDMO Service Market - Global Forecast 2025-2030- Product Image
Live Biotherapeutic Products CDMO Service Market - Global Forecast 2025-2030- Product Image
Sale

Live Biotherapeutic Products CDMO Service Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 181 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6129974
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Live biotherapeutic products represent a pivotal advancement in modern therapeutics, leveraging living microorganisms for targeted disease modulation and health restoration. As this innovative field progresses, specialized Contract Development and Manufacturing Organizations (CDMOs) are emerging as essential partners for biotech and pharmaceutical stakeholders seeking to overcome complex scientific, regulatory, and operational challenges in the global live biotherapeutic CDMO market.

Market Snapshot: Live Biotherapeutic CDMO Market

The live biotherapeutic CDMO market is experiencing robust growth, with companies responding to expanding demand from both large pharma and innovative biotech ventures. Factors fueling this momentum include increased investment in next-generation microbial therapies, a surge in clinical trial activity, and regulatory shifts supporting microbiome-based products. Market expansion is also shaped by the integration of end-to-end development services and advanced production capabilities, ensuring efficient scale-up and commercial supply of live biotherapeutics.

Scope & Segmentation of the Global Live Biotherapeutic CDMO Market

  • Service Type: Analytical services (microbiological testing, potency assays, purity testing); Clinical manufacturing (Phase I, II, III); Commercial manufacturing (bulk manufacturing, fill and finish); Process development (downstream, formulation, upstream development).
  • Production Scale: Clinical scale (Phase I, II, III); Commercial scale (large batch, small batch production).
  • Product Type: Engineered microbes (gene-edited, synthetic biology strains); Fecal microbiota transplant (fresh, processed material); Probiotics (multi-strain, single-strain).
  • Technology Platform: Cell-free production (in vitro transcription, translation); Fermentation (continuous, fed-batch); Freeze drying (lyophilization, spray drying).
  • Client Type: Academic institutions (government centers, non-profit organizations); Large pharma (top 10 companies); Small and mid-sized biotech (independent, VC-backed).
  • End Use Application: Gastrointestinal therapy (IBD, IBS); Metabolic disorders (diabetes, obesity); Oncology (hematologic malignancies, solid tumors).
  • Regions Covered: Americas (United States, Canada, Mexico, Brazil, Argentina, and major US states); Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, key MENA and EU markets); Asia-Pacific (China, India, Japan, Australia, South Korea, and leading Southeast Asian countries).
  • Major Industry Players Assessed: Thermo Fisher Scientific Inc., Lonza Group AG, Catalent, Inc., WuXi Biologics Co., Ltd., Samsung Biologics Co., Ltd., Fujifilm Diosynth Biotechnologies UK Ltd., Boehringer Ingelheim International GmbH, AGC Biologics Co., Ltd., Recipharm AB, BioVectra Inc.

Key Takeaways for Senior Decision-Makers

  • Integrated service platforms streamline analytical through commercial-scale manufacturing, reducing development timelines and risk of interdepartmental misalignment.
  • Technological innovations such as cell-free production and modular fermentation now enable agile, scalable solutions, addressing supply chain stability and regulatory compliance.
  • Market segmentation by product type and application reveals diverse regulatory and operational requirements, particularly for novel engineered microbes and probiotic consortia.
  • Regional trends affect manufacturing strategies, with North America leveraging investment and regulatory support, while Asia-Pacific and EMEA offer expanding capacity and specialized production environments.
  • Sustainability initiatives—such as single-use technologies and eco-friendly logistics—are emerging as differentiation factors in client and CDMO partnerships.
  • Strategic alliances with academic centers, government research institutes, and patient advocacy groups foster co-development and innovation for emerging therapeutic areas.

Tariff Impact on Supply Chain and Competitiveness

Newly imposed United States tariffs on critical inputs—including enzymes, reagents, and bioprocess equipment—have increased production costs throughout the live biotherapeutic CDMO market. CDMOs are optimizing procurement strategies, from dual-sourcing to regional supplier partnerships, to counter inflationary pressure and minimize delays. Proactive inventory management and enhanced customs coordination are now vital for maintaining clinical and commercial project continuity.

Primary Keyword: Live Biotherapeutic CDMO Market

Methodology & Data Sources

This research applies a blended methodology, combining qualitative interviews with senior sector executives, lead scientists, and regulators, and a rigorous secondary analysis of peer-reviewed publications, clinical trial databases, patent records, and industry white papers. A multi-stage validation process—featuring expert panel review and cross-reference of open-source data—ensures the accuracy and reliability of all findings presented.

Why This Report Matters

  • Empowers strategic decision-making by surfacing actionable insights across technology, market segmentation, and global supply dynamics.
  • Enables portfolio optimization and risk mitigation for executives navigating new regulatory frameworks, evolving clinical demands, and tariff-driven cost challenges.
  • Supports value-driven partnership selection and opportunity assessment in an increasingly competitive and dynamic live biotherapeutic CDMO landscape.

Conclusion

The live biotherapeutic CDMO market is advancing rapidly, shaped by technological, regulatory, and regional influences. In this environment, organizations positioned for agility and scientific excellence will drive successful outcomes for both established and emerging therapeutic programs.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing demand for personalized microbiome therapeutics driving bespoke CDMO service offerings
5.2. Regulatory harmonization initiatives streamlining live biotherapeutic product approval pathways across regions
5.3. Integration of anaerobic fermentation and closed-system bioreactors for enhanced LBP manufacturing scale-up
5.4. Strategic collaborations between CDMOs and biotech innovators accelerating live biotherapeutic pipeline progression
5.5. Implementation of advanced analytics and PAT tools for real-time monitoring of live microbial product quality
5.6. Development of robust cold chain and lyophilization logistics to ensure LBP stability during distribution
5.7. Adoption of synthetic biology approaches for custom strain engineering in live biotherapeutic CDMO services
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Live Biotherapeutic Products CDMO Service Market, by Service Type
8.1. Introduction
8.2. Analytical Services
8.2.1. Microbiological Testing
8.2.2. Potency Assays
8.2.3. Purity Testing
8.3. Clinical Manufacturing
8.3.1. Phase I
8.3.2. Phase II
8.3.3. Phase III
8.4. Commercial Manufacturing
8.4.1. Bulk Manufacturing
8.4.2. Fill And Finish
8.5. Process Development
8.5.1. Downstream Development
8.5.2. Formulation Development
8.5.3. Upstream Development
9. Live Biotherapeutic Products CDMO Service Market, by Production Scale
9.1. Introduction
9.2. Clinical Scale
9.2.1. Phase I Scale
9.2.2. Phase II Scale
9.2.3. Phase III Scale
9.3. Commercial Scale
9.3.1. Large Batch Production
9.3.2. Small Batch Production
10. Live Biotherapeutic Products CDMO Service Market, by Product Type
10.1. Introduction
10.2. Engineered Microbes
10.2.1. Gene-Edited Strains
10.2.2. Synthetic Biology Strains
10.3. Fecal Microbiota Transplant
10.3.1. Fresh Material
10.3.2. Processed Material
10.4. Probiotics
10.4.1. Multi-Strain
10.4.2. Single-Strain
11. Live Biotherapeutic Products CDMO Service Market, by Technology Platform
11.1. Introduction
11.2. Cell-Free Production
11.2.1. In Vitro Transcription
11.2.2. In Vitro Translation
11.3. Fermentation
11.3.1. Continuous
11.3.2. Fed-Batch
11.4. Freeze Drying
11.4.1. Lyophilization
11.4.2. Spray Drying
12. Live Biotherapeutic Products CDMO Service Market, by Client Type
12.1. Introduction
12.2. Academic Institutions
12.2.1. Government Research Centers
12.2.2. Non-Profit Research Organizations
12.3. Large Pharma
12.3.1. Top 10 Pharma
12.4. Small And Mid-Sized Biotech
12.4.1. Independent Biotech
12.4.2. VC-Backed Biotech
13. Live Biotherapeutic Products CDMO Service Market, by End Use Application
13.1. Introduction
13.2. Gastrointestinal
13.2.1. IBD
13.2.2. IBS
13.3. Metabolic Disorders
13.3.1. Diabetes
13.3.2. Obesity
13.4. Oncology
13.4.1. Hematologic Malignancies
13.4.2. Solid Tumors
14. Americas Live Biotherapeutic Products CDMO Service Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Live Biotherapeutic Products CDMO Service Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Live Biotherapeutic Products CDMO Service Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Thermo Fisher Scientific Inc.
17.3.2. Lonza Group AG
17.3.3. Catalent, Inc.
17.3.4. WuXi Biologics Co., Ltd.
17.3.5. Samsung Biologics Co., Ltd.
17.3.6. Fujifilm Diosynth Biotechnologies UK Ltd.
17.3.7. Boehringer Ingelheim International GmbH
17.3.8. AGC Biologics Co., Ltd.
17.3.9. Recipharm AB
17.3.10. BioVectra Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PRODUCTION SCALE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PRODUCTION SCALE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2030 (%)
FIGURE 12. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY CLIENT TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY CLIENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY END USE APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY END USE APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET: RESEARCHAI
FIGURE 28. LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET: RESEARCHSTATISTICS
FIGURE 29. LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET: RESEARCHCONTACTS
FIGURE 30. LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY ANALYTICAL SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY ANALYTICAL SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY MICROBIOLOGICAL TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY MICROBIOLOGICAL TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY POTENCY ASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY POTENCY ASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PURITY TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PURITY TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY ANALYTICAL SERVICES, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY ANALYTICAL SERVICES, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY CLINICAL MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY CLINICAL MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PHASE I, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PHASE I, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PHASE II, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PHASE II, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PHASE III, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PHASE III, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY CLINICAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY CLINICAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY COMMERCIAL MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY COMMERCIAL MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY BULK MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY BULK MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY FILL AND FINISH, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY FILL AND FINISH, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY COMMERCIAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY COMMERCIAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PROCESS DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PROCESS DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY DOWNSTREAM DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY DOWNSTREAM DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY FORMULATION DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY FORMULATION DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY UPSTREAM DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY UPSTREAM DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PROCESS DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PRODUCTION SCALE, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PRODUCTION SCALE, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY CLINICAL SCALE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY CLINICAL SCALE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PHASE I SCALE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PHASE I SCALE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PHASE II SCALE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PHASE II SCALE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PHASE III SCALE, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PHASE III SCALE, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY CLINICAL SCALE, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY CLINICAL SCALE, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY COMMERCIAL SCALE, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY COMMERCIAL SCALE, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY LARGE BATCH PRODUCTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY LARGE BATCH PRODUCTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY SMALL BATCH PRODUCTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY SMALL BATCH PRODUCTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY COMMERCIAL SCALE, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY COMMERCIAL SCALE, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY ENGINEERED MICROBES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY ENGINEERED MICROBES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY GENE-EDITED STRAINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY GENE-EDITED STRAINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY SYNTHETIC BIOLOGY STRAINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY SYNTHETIC BIOLOGY STRAINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY ENGINEERED MICROBES, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY ENGINEERED MICROBES, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY FECAL MICROBIOTA TRANSPLANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY FECAL MICROBIOTA TRANSPLANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY FRESH MATERIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY FRESH MATERIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PROCESSED MATERIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PROCESSED MATERIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY FECAL MICROBIOTA TRANSPLANT, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY FECAL MICROBIOTA TRANSPLANT, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PROBIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY MULTI-STRAIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY MULTI-STRAIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY SINGLE-STRAIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY SINGLE-STRAIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PROBIOTICS, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PROBIOTICS, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY CELL-FREE PRODUCTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY CELL-FREE PRODUCTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY IN VITRO TRANSCRIPTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY IN VITRO TRANSCRIPTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY IN VITRO TRANSLATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY IN VITRO TRANSLATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY CELL-FREE PRODUCTION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY CELL-FREE PRODUCTION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY FERMENTATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY FERMENTATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY CONTINUOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY CONTINUOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY FED-BATCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY FED-BATCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY FERMENTATION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY FERMENTATION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY FREEZE DRYING, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY FREEZE DRYING, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY LYOPHILIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY LYOPHILIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY SPRAY DRYING, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY SPRAY DRYING, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY FREEZE DRYING, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY FREEZE DRYING, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY CLIENT TYPE, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY CLIENT TYPE, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY GOVERNMENT RESEARCH CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY GOVERNMENT RESEARCH CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY NON-PROFIT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY NON-PROFIT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY LARGE PHARMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY LARGE PHARMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY TOP 10 PHARMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY TOP 10 PHARMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY LARGE PHARMA, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY LARGE PHARMA, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY SMALL AND MID-SIZED BIOTECH, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY SMALL AND MID-SIZED BIOTECH, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY INDEPENDENT BIOTECH, BY REGION, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY INDEPENDENT BIOTECH, BY REGION, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY VC-BACKED BIOTECH, BY REGION, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY VC-BACKED BIOTECH, BY REGION, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY SMALL AND MID-SIZED BIOTECH, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY SMALL AND MID-SIZED BIOTECH, 2025-2030 (USD MILLION)
TABLE 145. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY END USE APPLICATION, 2018-2024 (USD MILLION)
TABLE 146. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY END USE APPLICATION, 2025-2030 (USD MILLION)
TABLE 147. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 148. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 149. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY IBD, BY REGION, 2018-2024 (USD MILLION)
TABLE 150. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY IBD, BY REGION, 2025-2030 (USD MILLION)
TABLE 151. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY IBS, BY REGION, 2018-2024 (USD MILLION)
TABLE 152. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY IBS, BY REGION, 2025-2030 (USD MILLION)
TABLE 153. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
TABLE 154. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY GASTROINTESTINAL, 2025-2030 (USD MILLION)
TABLE 155. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 156. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 157. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY DIABETES, BY REGION, 2018-2024 (USD MILLION)
TABLE 158. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY DIABETES, BY REGION, 2025-2030 (USD MILLION)
TABLE 159. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY OBESITY, BY REGION, 2018-2024 (USD MILLION)
TABLE 160. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY OBESITY, BY REGION, 2025-2030 (USD MILLION)
TABLE 161. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY METABOLIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 162. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY METABOLIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 163. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 164. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 165. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 166. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 167. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 168. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY SOLID TUMORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 169. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 170. GLOBAL LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 173. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY ANALYTICAL SERVICES, 2018-2024 (USD MILLION)
TABLE 174. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY ANALYTICAL SERVICES, 2025-2030 (USD MILLION)
TABLE 175. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY CLINICAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 176. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY CLINICAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 177. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY COMMERCIAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 178. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY COMMERCIAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 179. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 180. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PROCESS DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 181. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PRODUCTION SCALE, 2018-2024 (USD MILLION)
TABLE 182. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PRODUCTION SCALE, 2025-2030 (USD MILLION)
TABLE 183. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY CLINICAL SCALE, 2018-2024 (USD MILLION)
TABLE 184. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY CLINICAL SCALE, 2025-2030 (USD MILLION)
TABLE 185. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY COMMERCIAL SCALE, 2018-2024 (USD MILLION)
TABLE 186. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY COMMERCIAL SCALE, 2025-2030 (USD MILLION)
TABLE 187. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 188. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 189. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY ENGINEERED MICROBES, 2018-2024 (USD MILLION)
TABLE 190. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY ENGINEERED MICROBES, 2025-2030 (USD MILLION)
TABLE 191. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY FECAL MICROBIOTA TRANSPLANT, 2018-2024 (USD MILLION)
TABLE 192. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY FECAL MICROBIOTA TRANSPLANT, 2025-2030 (USD MILLION)
TABLE 193. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PROBIOTICS, 2018-2024 (USD MILLION)
TABLE 194. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PROBIOTICS, 2025-2030 (USD MILLION)
TABLE 195. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 196. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 197. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY CELL-FREE PRODUCTION, 2018-2024 (USD MILLION)
TABLE 198. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY CELL-FREE PRODUCTION, 2025-2030 (USD MILLION)
TABLE 199. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY FERMENTATION, 2018-2024 (USD MILLION)
TABLE 200. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY FERMENTATION, 2025-2030 (USD MILLION)
TABLE 201. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY FREEZE DRYING, 2018-2024 (USD MILLION)
TABLE 202. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY FREEZE DRYING, 2025-2030 (USD MILLION)
TABLE 203. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY CLIENT TYPE, 2018-2024 (USD MILLION)
TABLE 204. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY CLIENT TYPE, 2025-2030 (USD MILLION)
TABLE 205. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 206. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 207. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY LARGE PHARMA, 2018-2024 (USD MILLION)
TABLE 208. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY LARGE PHARMA, 2025-2030 (USD MILLION)
TABLE 209. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY SMALL AND MID-SIZED BIOTECH, 2018-2024 (USD MILLION)
TABLE 210. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY SMALL AND MID-SIZED BIOTECH, 2025-2030 (USD MILLION)
TABLE 211. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY END USE APPLICATION, 2018-2024 (USD MILLION)
TABLE 212. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY END USE APPLICATION, 2025-2030 (USD MILLION)
TABLE 213. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
TABLE 214. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY GASTROINTESTINAL, 2025-2030 (USD MILLION)
TABLE 215. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY METABOLIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 216. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY METABOLIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 217. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 218. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 219. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 220. AMERICAS LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 221. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 222. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 223. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY ANALYTICAL SERVICES, 2018-2024 (USD MILLION)
TABLE 224. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY ANALYTICAL SERVICES, 2025-2030 (USD MILLION)
TABLE 225. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY CLINICAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 226. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY CLINICAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 227. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY COMMERCIAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 228. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY COMMERCIAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 229. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 230. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PROCESS DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 231. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PRODUCTION SCALE, 2018-2024 (USD MILLION)
TABLE 232. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PRODUCTION SCALE, 2025-2030 (USD MILLION)
TABLE 233. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY CLINICAL SCALE, 2018-2024 (USD MILLION)
TABLE 234. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY CLINICAL SCALE, 2025-2030 (USD MILLION)
TABLE 235. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY COMMERCIAL SCALE, 2018-2024 (USD MILLION)
TABLE 236. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY COMMERCIAL SCALE, 2025-2030 (USD MILLION)
TABLE 237. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 238. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 239. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY ENGINEERED MICROBES, 2018-2024 (USD MILLION)
TABLE 240. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY ENGINEERED MICROBES, 2025-2030 (USD MILLION)
TABLE 241. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY FECAL MICROBIOTA TRANSPLANT, 2018-2024 (USD MILLION)
TABLE 242. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY FECAL MICROBIOTA TRANSPLANT, 2025-2030 (USD MILLION)
TABLE 243. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PROBIOTICS, 2018-2024 (USD MILLION)
TABLE 244. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY PROBIOTICS, 2025-2030 (USD MILLION)
TABLE 245. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 246. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 247. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY CELL-FREE PRODUCTION, 2018-2024 (USD MILLION)
TABLE 248. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY CELL-FREE PRODUCTION, 2025-2030 (USD MILLION)
TABLE 249. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY FERMENTATION, 2018-2024 (USD MILLION)
TABLE 250. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY FERMENTATION, 2025-2030 (USD MILLION)
TABLE 251. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY FREEZE DRYING, 2018-2024 (USD MILLION)
TABLE 252. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY FREEZE DRYING, 2025-2030 (USD MILLION)
TABLE 253. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY CLIENT TYPE, 2018-2024 (USD MILLION)
TABLE 254. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY CLIENT TYPE, 2025-2030 (USD MILLION)
TABLE 255. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 256. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 257. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY LARGE PHARMA, 2018-2024 (USD MILLION)
TABLE 258. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY LARGE PHARMA, 2025-2030 (USD MILLION)
TABLE 259. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY SMALL AND MID-SIZED BIOTECH, 2018-2024 (USD MILLION)
TABLE 260. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY SMALL AND MID-SIZED BIOTECH, 2025-2030 (USD MILLION)
TABLE 261. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY END USE APPLICATION, 2018-2024 (USD MILLION)
TABLE 262. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY END USE APPLICATION, 2025-2030 (USD MILLION)
TABLE 263. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
TABLE 264. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE MARKET SIZE, BY GASTROINTESTINAL, 2025-2030 (USD MILLION)
TABLE 265. UNITED STATES LIVE BIOTHERAPEUTIC PRODUCTS CDMO SERVICE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Live Biotherapeutic Products CDMO Service market report include:
  • Thermo Fisher Scientific Inc.
  • Lonza Group AG
  • Catalent, Inc.
  • WuXi Biologics Co., Ltd.
  • Samsung Biologics Co., Ltd.
  • Fujifilm Diosynth Biotechnologies UK Ltd.
  • Boehringer Ingelheim International GmbH
  • AGC Biologics Co., Ltd.
  • Recipharm AB
  • BioVectra Inc.

Related Topics

Related Reports

Live Biotherapeutic Products & Microbiome CDMO Service Market - Global Forecast 2025-2030 - Product Image

Live Biotherapeutic Products & Microbiome CDMO Service Market - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Live Biotherapeutic Products and Microbiome CDMO Market Size, Share & Trends Analysis Report by Application (C. Difficile, Crohn's Disease, IBS, Diabetes), Region (North America, Europe, APAC, MEA) with Growth Forecasts, 2025-2030 - Product Image

Live Biotherapeutic Products and Microbiome CDMO Market Size, Share & Trends Analysis Report by Application (C. Difficile, Crohn's Disease, IBS, Diabetes), Region (North America, Europe, APAC, MEA) with Growth Forecasts, 2025-2030

  • Report
  • 137 Pages
  • Global
From
Live Biotherapeutic Products and Microbiome CDMO - Global Strategic Business Report - Product Image

Live Biotherapeutic Products and Microbiome CDMO - Global Strategic Business Report

  • Report
  • 108 Pages
  • Global
From
Live Biotherapeutics Products and Microbe CDMO Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Live Biotherapeutics Products and Microbe CDMO Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 184 Pages
  • Global
From
Postbiotics CDMO Service Market - Global Forecast 2025-2030 - Product Image

Postbiotics CDMO Service Market - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.